Richard J. D. Hatley

1.8k total citations · 1 hit paper
19 papers, 1.5k citations indexed

About

Richard J. D. Hatley is a scholar working on Organic Chemistry, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, Richard J. D. Hatley has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Immunology and Allergy and 5 papers in Molecular Biology. Recurrent topics in Richard J. D. Hatley's work include Cell Adhesion Molecules Research (6 papers), Catalytic C–H Functionalization Methods (3 papers) and Advanced Synthetic Organic Chemistry (3 papers). Richard J. D. Hatley is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), Catalytic C–H Functionalization Methods (3 papers) and Advanced Synthetic Organic Chemistry (3 papers). Richard J. D. Hatley collaborates with scholars based in United Kingdom, United States and Canada. Richard J. D. Hatley's co-authors include Elizabeth M. Beck, Matthew J. Gaunt, Simon J. F. Macdonald, Robert J. Slack, Neil P. Grimster, James A. Roper, Gísli Jenkins, Carmel B. Nanthakumar, Jack Gauldie and Richard P. Marshall and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Reviews Drug Discovery.

In The Last Decade

Richard J. D. Hatley

19 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging therapeutic opportunities for integrin inhibitors

2021 352 citations Robert J. Slack, Simon J. F. Macdonald et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard J. D. Hatley United Kingdom	12	765	357	211	135	112	19	1.5k
Xudong Wei China	20	501 0.7×	528 1.5×	57 0.3×	229 1.7×	212 1.9×	120	1.4k
Charles E. Hammond United States	18	318 0.4×	233 0.7×	156 0.7×	152 1.1×	188 1.7×	49	1.0k
Hirokazu Iida Japan	17	321 0.4×	339 0.9×	177 0.8×	97 0.7×	96 0.9×	57	900
Sunita Bhagat India	15	364 0.5×	326 0.9×	75 0.4×	225 1.7×	35 0.3×	66	904
Ko‐Chung Lin United States	12	223 0.3×	275 0.8×	258 1.2×	117 0.9×	151 1.3×	13	736
Robert J. Slack United Kingdom	22	282 0.4×	601 1.7×	330 1.6×	275 2.0×	486 4.3×	80	1.6k
Matthew Ho United States	14	541 0.7×	643 1.8×	22 0.1×	322 2.4×	139 1.2×	39	1.5k
Jean-Pascal Hérault France	22	390 0.5×	757 2.1×	53 0.3×	247 1.8×	67 0.6×	35	1.7k
Laurent Devel France	20	211 0.3×	638 1.8×	75 0.4×	634 4.7×	105 0.9×	43	1.4k
Milind Rajopadhye United States	18	255 0.3×	412 1.2×	264 1.3×	233 1.7×	76 0.7×	32	1.2k

Countries citing papers authored by Richard J. D. Hatley

Since Specialization

Citations

This map shows the geographic impact of Richard J. D. Hatley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. D. Hatley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. D. Hatley more than expected).

Fields of papers citing papers by Richard J. D. Hatley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. D. Hatley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. D. Hatley. The network helps show where Richard J. D. Hatley may publish in the future.

Co-authorship network of co-authors of Richard J. D. Hatley

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. D. Hatley. A scholar is included among the top collaborators of Richard J. D. Hatley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. D. Hatley. Richard J. D. Hatley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Barrett, John W., Glenn A. Burley, Richard J. D. Hatley, et al.. (2024). Core Modifications of GSK3335103 toward Orally Bioavailable α_vβ₆ Inhibitors with Improved Synthetic Tractability. Journal of Medicinal Chemistry. 67(21). 19689–19715. 3 indexed citations

Procopiou, Panayiotis A., John W. Barrett, Richard J. D. Hatley, et al.. (2024). Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α_vβ₆ Integrin Inhibitors. Journal of Medicinal Chemistry. 67(19). 17497–17519. 1 indexed citations

Slack, Robert J., Simon J. F. Macdonald, James A. Roper, Gísli Jenkins, & Richard J. D. Hatley. (2021). Emerging therapeutic opportunities for integrin inhibitors. Nature Reviews Drug Discovery. 21(1). 60–78. 352 indexed citations breakdown →

Hatley, Richard J. D., et al.. (2021). Synthetic approaches to N- and 4-substituted 1,4-dihydro-3(2H)-isoquinolinone derivatives. Tetrahedron. 100. 132455–132455. 1 indexed citations

Hatley, Richard J. D., et al.. (2020). Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors. Journal of Medicinal Chemistry. 63(23). 14336–14356. 2 indexed citations

Macdonald, Simon J. F. & Richard J. D. Hatley. (2020). Sprinkling the pixie dust: reflections on innovation and innovators in medicinal chemistry and drug discovery. Drug Discovery Today. 25(3). 599–609. 2 indexed citations

Hatley, Richard J. D., Robert J. Slack, Anna Gruszka, et al.. (2019). The Design of Potent, Selective and Drug‐Like RGD αvβ1 Small‐Molecule Inhibitors Derived from non‐RGD α4β1 Antagonists. ChemMedChem. 14(14). 1315–1320. 6 indexed citations

Hatley, Richard J. D., Simon J. F. Macdonald, Robert J. Slack, et al.. (2017). Ein Instrumentarium von αv‐RGD‐Integrin‐Inhibitoren: Wirkstoffsuche, Herausforderungen und Möglichkeiten. Angewandte Chemie. 130(13). 3354–3379. 12 indexed citations

Hatley, Richard J. D., Simon J. F. Macdonald, Robert J. Slack, et al.. (2017). An αv‐RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and Opportunities. Angewandte Chemie International Edition. 57(13). 3298–3321. 97 indexed citations

10.

Carlile, Graeme W., Renaud Robert, Elizabeth Matthes, et al.. (2016). Latonduine Analogs Restore F508del–Cystic Fibrosis Transmembrane Conductance Regulator Trafficking through the Modulation of Poly-ADP Ribose Polymerase 3 and Poly-ADP Ribose Polymerase 16 Activity. Molecular Pharmacology. 90(2). 65–79. 23 indexed citations

11.

Procopiou, Panayiotis A., Richard J. D. Hatley, Sean M. Lynn, et al.. (2016). Determination of the absolute configuration of (+)- and (−)-N-CBZ-3-fluoropyrrolidine-3-methanol using vibrational circular dichroism and confirmation of stereochemistry by conversion to (R)-tert-butyl 3-fluoro-3-(((R)-1-phenylethyl)carbamoyl)pyrrolidine-1-carboxylate. Tetrahedron Asymmetry. 27(24). 1222–1230. 5 indexed citations

12.

Nanthakumar, Carmel B., et al.. (2015). Dissecting fibrosis: therapeutic insights from the small-molecule toolbox. Nature Reviews Drug Discovery. 14(10). 693–720. 173 indexed citations

13.

Beck, Elizabeth M., Richard J. D. Hatley, & Matthew J. Gaunt. (2008). Synthesis of Rhazinicine by a Metal‐Catalyzed CH Bond Functionalization Strategy. Angewandte Chemie International Edition. 47(16). 3004–3007. 226 indexed citations

14.

Beck, Elizabeth M., Richard J. D. Hatley, & Matthew J. Gaunt. (2008). Synthesis of Rhazinicine by a Metal‐Catalyzed CH Bond Functionalization Strategy. Angewandte Chemie. 120(16). 3046–3049. 97 indexed citations

15.

Beck, Elizabeth M., Neil P. Grimster, Richard J. D. Hatley, & Matthew J. Gaunt. (2006). Mild Aerobic Oxidative Palladium (II) Catalyzed C−H Bond Functionalization: Regioselective and Switchable C−H Alkenylation and Annulation of Pyrroles. Journal of the American Chemical Society. 128(8). 2528–2529. 323 indexed citations

16.

Borthwick, Alan D., Anne M. Exall, Richard J. D. Hatley, et al.. (2006). 2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 3. Synthesis, Pharmacokinetics, and in Vivo Potency. Journal of Medicinal Chemistry. 49(14). 4159–4170. 34 indexed citations

17.

Wyatt, Paul G., Michael Allen, Alan D. Borthwick, et al.. (2005). 2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: identification, stereochemistry and initial SAR. Bioorganic & Medicinal Chemistry Letters. 15(10). 2579–2582. 50 indexed citations

18.

Robertson, Jeremy, Richard J. D. Hatley, & D.J. Watkin. (2000). Preparation of the tricyclic ketopyrrole core of roseophilin by radical macrocyclisation and Paal–Knorr condensation. Journal of the Chemical Society Perkin Transactions 1. 3389–3396. 33 indexed citations

19.

Robertson, Jeremy & Richard J. D. Hatley. (1999). Formal synthesis of roseophilin. Chemical Communications. 1455–1456. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact